Drug Profile
Isotretinoin - Cipher Pharmaceuticals
Alternative Names: Absorica; Absorica AG; ABSORICA LD; CIP-isotretinoin; Epuris; Isotretinoin - Cipher; Lisacne-CIP; Semi-liquid isotretinoin capsules - CipherLatest Information Update: 06 Dec 2023
Price :
$50
*
At a glance
- Originator Cipher Pharmaceuticals
- Developer Andromaco; Cipher Pharmaceuticals; Sun Pharmaceutical Industries
- Class Anti-inflammatories; Antiacnes; Antineoplastics; Keratolytics; Retinoids; Skin disorder therapies; Small molecules
- Mechanism of Action Ornithine decarboxylase inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Acne